Absci (NASDAQ:ABSI) Bolsa

ABSCI CORP

Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Stock,Market,Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ABSI

ALLT

ALUR

ASNS

AXDX

DBVT

DEVS

FNGR

GRAL

LRHC

LUCY

PLRZ

UBER

WBUY

XHLD

XTKG

Las acciones de Everus Construction Group suben un 14,7 % tras superar expectativas de ganancias y ventas en el primer trimestre.

Acciones de Everus Construction (ECG) se disparan un 15%; Aquí están 20 acciones que se mueven en premercado

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Descubre las recientes decisiones de Ark Invest en energía, defensa y genética, con transacciones millonarias en empresas clave.

Ark Invest adquiere y vende acciones clave en energía, defensa y tecnología genética

Equities

General

INTC

NVDA

Absci Corporation y AMD se unen para transformar el descubrimiento de medicamentos mediante inteligencia artificial avanzada.

Absci y AMD se asocian para revolucionar el descubrimiento de medicamentos con IA

Absci Corp

Updated 2025 Guidance
Vermilion is adjusting its 2025 capital budget to a range of $630 to $660 million, reflecting a reduction of approximately $100 million from the mid-point of our previous capital budget range of $730 to $760 million. This reduction reflects the removal of all remaining E&amp;D capital associated with the Saskatchewan and United States divested assets post-closing. Vermilion expects full year and second half 2025 production to range between 117,000 to 122,000 boe/d, 68% natural gas-weighted in the second half of 2025. On a go-forward basis, it is estimated that over 90% of production will come from our global gas portfolio and over 80% of capital is expected be allocated to these assets. Vermilion will continue to evaluate capital investment levels during this period of increased volatility and will adjust capital if necessary to prioritize free cash flow over production growth during 2025 and 2026.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Category</td>
<td colspan="1" rowspan="1">
Original
2025 Guidance&#x2A;
</td>
<td colspan="1" rowspan="1">
Post-Westbrick
2025 Guidance&#x2A;
</td>
<td colspan="1" rowspan="1">
Updated&nbsp;
2025 Guidance&#x2A;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Production (boe/d)</td>
<td colspan="1" rowspan="1">84,000 – 88,000</td>
<td colspan="1" rowspan="1">125,000 – 130,000</td>
<td colspan="1" rowspan="1">117,000 – 122,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">% Natural Gas</td>
<td colspan="1" rowspan="1">56&nbsp;%</td>
<td colspan="1" rowspan="1">62&nbsp;%</td>
<td colspan="1" rowspan="1">65&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">E&amp;D capital expenditures ($MM)</td>
<td colspan="1" rowspan="1">$600 – 625</td>
<td colspan="1" rowspan="1">$730 – 760</td>
<td colspan="1" rowspan="1">$630 – 660</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Royalty rate (% of sales)</td>
<td colspan="1" rowspan="1">8 – 10%</td>
<td colspan="1" rowspan="1">9 – 11%</td>
<td colspan="1" rowspan="1">8 – 10%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating ($/boe)</td>
<td colspan="1" rowspan="1">$17.00 – 18.00</td>
<td colspan="1" rowspan="1">$13.50 – 14.50</td>
<td colspan="1" rowspan="1">$13.00 – 14.00</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Transportation ($/boe)</td>
<td colspan="1" rowspan="1">$3.50 – 4.00</td>
<td colspan="1" rowspan="1">$3.00 – 3.50</td>
<td colspan="1" rowspan="1">$3.00 – 3.50</td>
</tr>
<tr>
<td colspan="1" rowspan="1">General and administration ($/boe)&#x2A;&#x2A;</td>
<td colspan="1" rowspan="1">$2.75 – 3.25</td>
<td colspan="1" rowspan="1">$2.25 – 2.75</td>
<td colspan="1" rowspan="1">$2.25 – 2.75</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cash taxes (% of pre-tax FFO)</td>
<td colspan="1" rowspan="1">7 – 9%</td>
<td colspan="1" rowspan="1">6 – 10%</td>
<td colspan="1" rowspan="1">4 – 8%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Asset retirement obligations settled ($MM)</td>
<td colspan="1" rowspan="1">$60</td>
<td colspan="1" rowspan="1">$60</td>
<td colspan="1" rowspan="1">$60</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Payments on lease obligations ($MM)</td>
<td colspan="1" rowspan="1">$20</td>
<td colspan="1" rowspan="1">$20</td>
<td colspan="1" rowspan="1">$15</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Commodities

Vermilion Energy Adjusts 2025 Capital Budget To $630M-$660M, Reflecting A Reduction Of Approximately $100M From The Mid-point Of Previous Capital Budget Of $730M-$760M

Contracts

IperionX On Wednesday Announced Award Of U.S. Department Of Defense SBIR Phase III Contract For Up To $99M

– Enrollment Completed for Both Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Top-Line Data Expected End of 2026 –
– Additional Data from Phase 2 CALLIPER Trial in Progressive Multiple Sclerosis Further Supports the Recently Released Positive Top-Line Results and Further Underlines Vidofludimus Calcium's Neuroprotective Potential –
– New CALLIPER Data Regarding Time to 24-Week Confirmed Disability Worsening Shows Substantial and Medically Relevant Reductions for Vidofludimus Calcium Over Placebo in the Overall Study Population and Major Disease Subtypes –
NEW YORK, June 5, 2025 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4443060-1&amp;h=4233216002&amp;u=https%3A%2F%2Fimux.com%2F&amp;a=Immunic%2C+Inc.">Immunic, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMUX#NASDAQ">IMUX</a>),&nbsp;a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced the completion of enrollment for both phase 3 ENSURE trials of lead asset, nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with relapsing multiple sclerosis and additional phase 2 CALLIPER trial data in patients with progressive multiple sclerosis underlining the recently released positive top-line results.
Enrollment Completed for Both Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis (RMS)
The ENSURE program comprises two identical multicenter, randomized, double-blind phase 3 trials designed to evaluate the efficacy, safety and tolerability of vidofludimus calcium versus placebo in RMS patients. Each of the trials, titled ENSURE-1 and ENSURE-2, enrolled adult patients with active RMS at more than 100 sites in 15 countries, including the United States, India and countries in the Middle East and North Africa (MENA) region, Latin America, and Central and Eastern Europe. In total, 1,121 patients in ENSURE-1 and 1,100 patients in ENSURE-2 have been randomized in a double-blinded fashion to either 30 mg daily doses of vidofludimus calcium or placebo. The primary endpoint for both trials is time to first relapse up to 72 weeks. Secondary endpoints include time to confirmed disability worsening based on the Expanded Disability Status Scale (EDSS), volume of new T2-lesions, time to sustained clinically relevant changes in cognition, and magnetic resonance imaging (MRI)-based endpoints.

IMUX

Immunic Completes Enrollment For Both Phase 3 ENSURE Trials Of Vidofludimus Calcium In Relapsing Multiple Sclerosis; Top-Line Data Expected End Of 2026

<ul>
<li>$177 million in total consideration subject to customary fees and adjustments</li>
<li>Industrial, utility and data center power demand is increasing globally</li>
<li>B&amp;W now well-capitalized and poised to leverage growth in 2025 and beyond</li>
</ul>

B&W Announces Sale Of Diamond Power To ANDRITZ For $177M , Eyes Growth In Data Center And Utility Markets

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>) with a Buy and raises the price target from $11 to $11.5.

Price Target

Analyst Ratings

RNXT

Ascendiant Capital Maintains Buy on RenovoRx, Raises Price Target to $11.5

Life Time Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTH#NYSE">LTH</a>) ("Life Time" or the "Company") announced today that certain affiliates of Leonard Green &amp; Partners, L.P. and TPG Inc. (the "Selling Stockholders") intend to offer and sell 20,000,000 shares of the Company's common stock in an underwritten public offering pursuant to Life Time's shelf registration statement filed with the Securities and Exchange Commission (the "SEC"). The Selling Stockholders will receive all of the proceeds from the proposed offering. The Company will not receive any of the proceeds from the sale of shares of the Company's common stock by the Selling Stockholders. Following the consummation of the offering, the Company's voting group, which includes the Selling Stockholders, will hold approximately 43.1% of the Company's common stock.

Offerings

Life Time Shareholders Leonard Green, TPG to Sell 20M Shares in Public Offering

Net proceeds from the Transaction will be directed towards debt repayment to further accelerate deleveraging efforts and strengthen Vermilion's balance sheet. Based on current strip commodity pricing(1) and operational plans, we would expect to exit 2025 with net debt(2) of $1.3 billion, with a trailing net debt to FFO ratio(3) of 1.3 times.
The Assets consist of approximately 5,500 boe/d (81% oil and liquids) of production and approximately 10 mmboe of Proved Developed Producing reserves estimated as evaluated by McDaniel &amp; Associates Consultants Ltd. at December 31, 2024. The Transaction has an effective date of January 1, 2025 and is anticipated to close in Q3 2025, subject to the satisfaction of other customary closing conditions. The Transaction agreement includes $10 million of contingent payments(4) based on WTI prices over the two-year period starting July 1, 2025.
This Transaction, combined with the sale of our East Finn assets in 2023, completes our exit from the United States, allowing us to focus on our core gas-weighted assets in Canada and Europe. Vermilion would like to sincerely thank our talented and dedicated field teams in Wyoming for their commitment to safe and efficient operations over the past 11 years as well as the technical teams, which provided support from Denver and Calgary.

Vermilion Energy Agrees To Sell Its United States Assets For $120M

Wallbox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBX#NYSE">WBX</a>), a global leader in electric vehicle (EV) charging and energy management solutions, today announced two recent private placements of the Company's Class A ordinary shares for an aggregate of $15 million. The first is an investment of more than $9 million from the Government of Spain through the Spanish Society for Technological Transformation (SETT), which joins Wallbox's shareholder base as part of the Company's financing round from February 2025. Additionally, existing investors including Inversiones Financieras Perseo, S.L. (a subsidiary of Iberdrola), Orilla Asset Management, S.L., Wallbox CEO and Cofounder Enric Asunción, and others contributed more than $5 million through a second investment, reaffirming their continued support for Wallbox's growth and technological leadership.
The Spanish Society for Technological Transformation (SETT), a state-owned enterprise under the Ministry for Digital Transformatión and Public Administration, is a public entity dedicated to financing and promoting advanced and transformative technologies. With this investment, SETT supports Wallbox's leadership as a technological frontrunner in the energy transition.
This investment by SETT is made through the Next Tech initiative, which aims to encourage private investment and improve access to financing in strategic sectors of the Spanish economy through disruptive technologies. Next Tech is part of the Recovery, Transformation, and Resilience Plan and is one of the key instruments managed by SETT. In addition, SETT oversees two other financial tools designed to strengthen Spain's technological business ecosystem: PERTE Chip, focused on microelectronics and semiconductors, and the Spain Audiovisual Hub, which supports the digitalization and growth of the audiovisual sector.
These investments strengthen Wallbox's balance sheet and provide the resources to accelerate the global adoption of its EV charging solutions, advance the digitalization of its solutions, and drive the development of cutting-edge technologies for smarter, more efficient energy management.

Wallbox Secures $15M Investment, Including $9M From Spanish Government to Boost EV Tech

Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) with a Buy and raises the price target from $11 to $11.5.

Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $11.5

On Wednesday, June 4, U.S. markets closed mixed, as weak services and job data highlighted the toll of Trump&#8217;s policy uncertainty. The S&amp;P 500 was flat, the Nasdaq edged up, and the Dow dipped.
Investors weighed trade tensions, softening policy stances, and corporate earnings. Tesla and CrowdStrike fell, while HPE and GlobalFoundries gained. Trading volume remained light.
According to the economic data, the ISM services PMI fell to 49.9 in May, missing expectations, while private businesses added just 37K jobs, down from 60K in April.
Most S&amp;P 500 sectors rose Wednesday, led by communication services, materials, and real estate, while energy and utilities declined.
The Dow closed lower by 0.22% at 42,427.74, the S&amp;P 500 gained 0.01% to 5,970.81, and the Nasdaq rose 0.32% to 19,460.49.
<h2 class="wp-block-heading">Asia Markets Today</h2>
On Thursday, Japan&#8217;s Nikkei 225 closed 0.57% lower at 37,532.50, led by losses in the Paper &amp; Pulp, Transport and Communication sectors.
Australia&#8217; S&amp;P/ASX 200 slid 0.03%, ending the session at 8,538.90, led by losses in the Gold, Healthcare, and Utilities sectors.
India&#8217;s Nifty 50 was up 0.53% at 24,757.80, and the Nifty 500 rose 0.56% to 22,934.50.
China&#8217;s Shanghai Composite was up 0.23% at 3,384.10, and Shanghai Shenzhen CSI 300 gained 0.23% to 3,877.56.
Hong Kong&#8217;s Hang Seng closed the session 1.07% higher at 23,906.97.
<h2 class="wp-block-heading">Eurozone at 05:45 AM ET</h2>
The European STOXX 50 index was up 0.42%.
Germany&#8217;s DAX index gained 0.44%.
France&#8217;s CAC 40 rose 0.50%.
U.K.&#8217;s FTSE 100 index traded higher by 0.27%.
<h2 class="wp-block-heading">Commodities at 05:45 AM ET</h2>
Crude Oil WTI was trading higher by 0.29% at $63.01/bbl, and Brent was up 0.32% at $65.07/bbl.
Oil prices steadied after a 1% drop, pressured by rising U.S. fuel stockpiles, Saudi price cuts for Asia, soft demand signals, and weak global economic data.
Natural gas slid 0.57% to $3.695.
Gold traded higher by 0.49% to $3,416.17, Silver rose 3.19% to $35.753, and Copper rose 2.29% to $4.9968.
<h2 class="wp-block-heading">U.S. Futures at 05:45 AM ET</h2>
Dow Jones futures rose 0.11%, S&amp;P 500 gained 0.05%, and Nasdaq 100 was up 0.05%.
<h2 class="wp-block-heading">Forex at 05:45 AM ET</h2>
The U.S. Dollar Index slid 0.04% to 98.78, USD/JPY was up 0.24% to 143.10, and USD/AUD fell 0.33% to 1.5353.
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Gains, Gold Inches Toward All Time High - Global Markets Today While US Slept

Economist Craig Shapiro argues that the debt ceiling, a mechanism only used by the U.S. and Denmark, fails to curb excessive government spending and instead creates political theater every few years.
What Happened: Shapiro, who is a macro strategist at the Bear Traps Report highlights the Federal Reserve's role, noting its consistent interventions in the bond market.
According to him, these interventions, which include providing liquidity during market hiccups, have enabled Washington's unchecked spending by ensuring stable market function for U.S. Treasuries.
The Fed's actions, Shapiro contends, remove market discipline, as Congress and administrations rely on the Fed to backstop their fiscal policies, a dynamic he says has fueled deficit spending.
Recent data support this concern as the U.S. federal debt has nearly tripled since 2009, with the Treasury Department frequently hitting the congressionally mandated borrowing limit, according to the Council on Foreign Relations.
Shapiro suggests that if the Fed stepped back and allowed "bond vigilantes"—investors who sell bonds to protest fiscal policy, raising borrowing costs—to act, market forces could pressure Washington to curb spending, a tactic seen in emerging markets with unsustainable deficits.
&#8220;Ending it is probably a good thing but really won&#8217;t stop the spending in DC,&#8221; says Shapiro.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The debt ceiling prevents nothing. Only two countries in the world have a debt ceiling. The US and Denmark All it does is create a circus every few years as one party tries to hold up incessant spending by the other party in power, playing games with the USA credit rating as…
&mdash; Craig Shapiro (@ces921) <a href="https://twitter.com/ces921/status/1930390505390780869?ref_src=twsrc%5Etfw">June 4, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/06/45786854/magnificent-7-drive-54-of-market-cap-gains-in-sp-500-since-april-lows-the-market-cannot-survive-without-big-tech">Magnificent 7 Drive 54% Of Market Cap Gains In S&amp;P 500 Since April Lows: &#8216;The Market Cannot Survive Without Big Tech&#8217; </a>
Why It Matters: Without the debt ceiling, Shapiro warns, the Fed's role as an enabler must be addressed to impose real fiscal discipline on Washington.
Current Fed policy adds complexity, with the federal funds rate held at 4.25% to 4.50% in May 2025, and markets expecting two 0.25% rate cuts by year-end.
As of the publication of this article, the 10-year Treasury bond yielded 4.35% and the two-year bond was at 3.87%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 95.6% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Thursday. The SPY was up 0.099% at $596.52, while the QQQ advanced 0.093% to $529.26, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45764818/bill-ackman-urges-end-to-fannie-mae-freddie-mac-conservatorship-says-will-enable-them-to-operate-more-successfully-and-efficiently" target="_blank" rel="noreferrer noopener">Bill Ackman Urges End To Fannie Mae, Freddie Mac Conservatorship: Says Will Enable Them To ‘Operate More Successfully And Efficiently&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Photo courtesy: RozenskiP / Shutterstock.com

Federal Reserve

Debt Ceiling: How The Fed Fuels Washington's Spending Spree, 'Ending It Is Probably A Good Thing,' Says Expert

<a href="https://www.reuters.com/world/india/walmarts-flipkart-secures-approval-direct-lending-india-documents-show-2025-06-05/" title="https://www.reuters.com/world/india/walmarts-flipkart-secures-approval-direct-lending-india-documents-show-2025-06-05/">https://www.reuters.com/world/india/walmarts-flipkart-secures-approval-direct-lending-india-documents-show-2025-06-05/</a>

Personal Finance

INDA

Reuters Reported Walmart's Flipkart Secures Lending Licence From Indian Central Bank, Enabling Direct Loans To Customers, Sellers On Platform

Safe & Green Holdings Announced Stock Purchase Agreement With Generating Alpha for Sale of Up To  $100M Of Newly Issued Common Shares

<a href="https://www.wsj.com/business/retail/procter-gamble-to-cut-7-000-jobs-400a6a36?gaa_at=eafs&amp;gaa_n=ASWzDAhZcl-BL1P6MKQp-cGvBfrU7lwAjiLR23IuC_iCQjPmlx59LCFsFxBOkNEL33Y%3D&amp;gaa_ts=68417096&amp;gaa_sig=1SvYnZLSUqrHYEwYxICLtRK5qV9Xr8HGwWwNruDMzeoUzVpBInYIKzpLgDA-vfJj0UoHmeM8a5xB1CsLuORnbg%3D%3D" title="https://www.wsj.com/business/retail/procter-gamble-to-cut-7-000-jobs-400a6a36?gaa_at=eafs&amp;gaa_n=ASWzDAhZcl-BL1P6MKQp-cGvBfrU7lwAjiLR23IuC_iCQjPmlx59LCFsFxBOkNEL33Y%3D&amp;gaa_ts=68417096&amp;gaa_sig=1SvYnZLSUqrHYEwYxICLtRK5qV9Xr8HGwWwNruDMzeoUzVpBInYIKzpLgDA-vfJj0UoHmeM8a5xB1CsLuORnbg%3D%3D">https://www.wsj.com/business/retail/procter-gamble-to-cut-7-000-jobs-400a6a36?gaa_at=eafs&amp;gaa_n=ASWzDAhZcl-BL1P6MKQp-cGvBfrU7lwAjiLR23IuC_iCQjPmlx59LCFsFxBOkNEL33Y%3D&amp;gaa_ts=68417096&amp;gaa_sig=1SvYnZLSUqrHYEwYxICLtRK5qV9Xr8HGwWwNruDMzeoUzVpBInYIKzpLgDA-vfJj0UoHmeM8a5xB1CsLuORnbg%3D%3D</a>

The Wall Street Journal Reported Earlier,  Procter & Gamble To Cut 7,000 Jobs

Earnings

Yuanbao Reports Q1 2025 Sales Of $133.7M, EPS Of $0.15

ATIF Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>), today announced its strategic expansion into the Bitcoin (BTC) sector with an ambitious five-year plan to accumulate 1,000 BTC through a combination of direct purchases, and mining operations.
As part of this initiative, ATIF Holdings will deploy a hybrid approach in the next five years including:
<ul>
<li>- Direct acquisition of BTC in the open market;</li>
<li>- Building and Operating proprietary BTC mining facilities; and/or acquiring operating BTC mining sites</li>
</ul>
The company has tentatively selected West Texas as the primary location for its proprietary mining operations. This decision is driven by several key factors: Texas' favorable regulatory environment for digital asset mining, abundant and affordable land, and a well-developed, deregulated electricity market with competitive power costs. Additionally, ATIF Holdings aims to implement advanced power utilization strategies to further reduce production costs and enhance overall operational efficiency.
"We view Bitcoin not only as a long-term store of value but also as a strategic asset for growth and diversification," said Kamran Khan, the CEO. "Our investment in mining infrastructure—particularly in a power-efficient region like West Texas—positions us to participate directly in Bitcoin's network while optimizing cost control and scalability."
The planned mining facilities will emphasize energy efficiency, sustainable operations, and smart grid integration, aligning with broader industry trends towards responsible and forward-looking crypto infrastructure development.
The company has purchased BTC in the open market and plans to continue to do so in the near future. &nbsp;&nbsp;
This move marks a significant evolution in ATIF Holdings' business and underscores its commitment to innovation and long-term value creation in emerging technologies.

ZBAI

ATIF Holdings Unveils 5-Year Plan to Acquire 1,000 Bitcoin Through Mining and Direct Buys

<ul>
<li>DAZALS did not meet its primary endpoint of improved outcome in the ALS Functional Rating Scale-Revised (ALSFRS-R) in patients who received dazucorilant compared to patients who received placebo</li>
<li>DAZALS met its secondary endpoint of improved overall survival at week 24 of the study in patients who received 300 mg of dazucorilant compared to patients who received placebo</li>
<li>Exploratory analysis at the one-year mark shows continued significant improvement in overall survival between patients who received 300 mg of dazucorilant and those who received placebo only</li>
<li>Corcept seeking guidance from United States and European regulators on optimum path forward</li>
</ul>

Biotech

Health Care

CORT

Corcept Therapeutics Presented Results From Its DAZALS Study Of Dazucorilant In Patients With ALS At The European Network To Cure ALS 2025 Annual Meeting, DAZALS Did Not Meet Its Primary Endpoint Of Improved Outcome In The Als Functional Rating Scale-revised Compared To Placebo

Ascendiant Capital analyst Edward Woo maintains Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) with a Buy and raises the price target from $20 to $20.5.

PSTV

Ascendiant Capital Maintains Buy on Plus Therapeutics, Raises Price Target to $20.5

Former Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO Steve Ballmer publicly acknowledged the tech giant&#8217;s critical strategic error in mobile computing. 
What Happened: The admission highlights how overconfidence in Windows prevented Microsoft from capitalizing on the smartphone revolution that propelled Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Samsung Electronics Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) to market dominance.
During his 34-year Microsoft tenure discussion, Ballmer explained during a recent Acquired podcast appearance that Microsoft&#8217;s fundamental miscalculation with its mobile strategy.
&#8220;We were too confident,&#8221; Ballmer stated, describing how the company attempted to force Windows into unsuitable markets rather than developing platform-specific solutions.
&#8220;I don&#8217;t think we stuck with Windows too long. I think what we did is we tried to put Windows in places that it didn&#8217;t naturally go,&#8221; Ballmer said. He cited Windows Mobile and automotive applications as prime examples where Microsoft&#8217;s insistence on Windows APIs and user interfaces created unnatural product experiences.
The former CEO revealed that Microsoft&#8217;s approach stemmed from both &#8220;paranoia and confidence&#8221; in Windows as their &#8220;birthright&#8221; and &#8220;permission to enter&#8221; new market areas. This strategy extended to media center applications and TV integration, where simplified Windows layers failed to compete with purpose-built alternatives.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/45786145/trumps-50-steel-tariff-could-drive-up-the-costs-for-automakers-almost-2000-of-cost-for-each-car">Trump&#8217;s 50% Steel Tariff Could Drive Up The Costs For Automakers: &#8216;Almost $2,000 Of Cost For Each Car&#8217;</a>
Why It Matters: Ballmer&#8217;s mobile strategy failure represents one of technology&#8217;s <a href="https://www.benzinga.com/25/05/45458915/had-microsoft-built-phones-earlier-things-might-look-different-today-steve-ballmers-missed-call-now-worth-289000-to-apple-investors">most expensive missed opportunities</a>. In a 2014 interview, he admitted Microsoft should have pivoted to hardware manufacturing earlier, acknowledging that Apple and Samsung &#8220;both did it by making phones&#8221; to surpass Microsoft&#8217;s profitability leadership.
Microsoft maintains a $3.36 trillion market capitalization as one of the world&#8217;s most valuable companies. Ballmer&#8217;s Windows-centric approach contrasts sharply with CEO Satya Nadella&#8216;s transformation strategy, which embraced cloud services and strategic acquisitions like LinkedIn. Microsoft&#8217;s 2019 investment in OpenAI under Nadella finally enabled the company to challenge Google&#8216;s <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/11/35912780/steve-ballmer-vs-satya-nadella-one-microsoft-ceo-would-have-turned-your-1000-investment">dominance after decades of struggle</a>.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The Steve Ballmer Interview" width="500" height="281" src="https://www.youtube.com/embed/CYC49_aeop0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45786038/amazon-expands-cloud-ai-footprint-with-10-billion-data-center-investment-in-north-carolina">Amazon Expands Cloud, AI Footprint With $10 Billion Data Center Investment In North Carolina</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: katuSka on Shutterstock.com

AAPL

MSFT

SSNLF

Steve Ballmer Admits Microsoft Missed Mobile By Clinging To Windows: 'We Were Too Confident'

Needham analyst Tom Nikic reiterates PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Buy and maintains $115 price target.

Reiteration

Needham Reiterates Buy on PVH, Maintains $115 Price Target

Press Releases

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Participate in Upcoming Investor Conferences

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Comments

Absci

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL